The role of imaging techniques in clinical decision making for the management of hepatocellular carcinoma

Hepatology

Volumn 56, Issue 2, 2012, Pages 786-

  Lo, Gin Ho ^a  

^a I SHOU UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; CLATHRIN HEAVY CHAIN; GLUTAMATE AMMONIA LIGASE; GLYPICAN 3; HEAT SHOCK PROTEIN 70;

CANCER DIAGNOSIS; CANCER STAGING; CHEMOEMBOLIZATION; CLINICAL DECISION MAKING; COMPUTER ASSISTED TOMOGRAPHY; FOLLOW UP; HUMAN; IMAGING; IMMUNOHISTOCHEMISTRY; LETTER; LIVER CELL CARCINOMA; LYMPHADENOPATHY; MINIMAL RESIDUAL DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PORTAL VEIN; PRIORITY JOURNAL;

CARCINOMA, HEPATOCELLULAR; DIAGNOSTIC IMAGING; HUMANS; LIVER NEOPLASMS;

EID: 84864338154     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.25618     Document Type: Letter

References (2)

1. Bruix J, Reig M, Forner A, Burrel M, Vilana R, Ayuso C. Clinical decision making and research in hepatocellular carcinoma: pivotal role of imaging techniques. HEPATOLOGY 2011; 54: 2238-2244.
2. Chen DS, Sung JL. Serum alpha-fetoprotein in hepatocellular carcinoma. Cancer 1977; 40: 779-783.